Category: News

Quarterly Cash Distribution Payment Date Adjustment Due to Canadian Statutory Holiday

TORONTO, March 5, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN/DHT.U) (“DRI” or “the Trust”) today informs its unitholders of an adjustment to its previously announced quarterly cash distribution to unitholders of record as at March 31, 2025. This adjustment is required due to the occurrence of a Canadian statutory holiday on the originally scheduled payment date. The cash […]

DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results

Remediation of material weaknesses complete 45% increase in Normalized Total Cash Receipts over the prior year showcases continued execution and growth of portfolio Announcing 2025 royalty income guidance of $172 to $182 million, excluding milestone income and any new transactions, and increase in quarterly distribution to $0.10 per unit TORONTO, March 3, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the […]

DRI Healthcare Trust Declares Special Unit Distribution

TORONTO, Dec. 20, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, announces that in accordance with the requirement for the Trust to distribute all of its taxable income for the year, its Board of Trustees has declared […]

DRI Healthcare Trust Reports Third Quarter 2024 Results

53% adjusted EBITDA growth over prior year period shows strong focus on cash generation Recent acquisitions and credit facility expansion highlight growth under new leadership  TORONTO, Nov. 6, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced its financial results for the quarter ended September 30, 2024. The Trust’s third […]

DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista Pharmaceuticals

– First pre-approval royalty acquisition and first equity investment highlight evolving investment strategy – – Up to US$184 million investment brings capital deployment to over US$1 billion since IPO – – Long-term asset in new therapeutic area further increases portfolio duration and diversification – TORONTO, Nov. 4, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: […]

DRI Healthcare Trust Announces Upsized US$631.6 Million Credit Facilities

– Enhances deployment capacity without increasing leverage parameters – – Sufficient funding to achieve 2025 deployment target – – Marginal decrease in interest rate and standby fees – TORONTO, Nov. 1, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in the life […]

DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)

– Transaction adds another innovative rare disease therapy to the DHT portfolio – – Novel deal structure offers predictable annual cash flows as well as potential additional annual sales-based milestones and a one-time contingent payment – TORONTO, Oct. 3, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") today announced that a wholly […]

DRI Capital Inc. Updates Executive Changes

TORONTO, September 27, 2024  – DRI Healthcare Trust recently announced that its investigation into consulting and other expenses submitted had substantially concluded. DRI did not find Chris Anastasopoulos to have submitted any inappropriate consulting or other expenses. Mr. Anastasopoulos has since advised DRI Capital that he has decided to resign to pursue other opportunities. He will remain […]